Safety of nanoparticles in medicine
Nanomedicine involves the use of nanoparticles for therapeutic and diagnostic purposes.
During the past two decades, a growing number of nanomedicines have received regulatory …
During the past two decades, a growing number of nanomedicines have received regulatory …
Advances in liposomal drug delivery to cancer: An overview
Liposomes are biodegradable and biocompatible lipid bilayer vesicles which are widely
exploited as preferred carriers for smart delivery of both hydrophobic as well as hydrophilic …
exploited as preferred carriers for smart delivery of both hydrophobic as well as hydrophilic …
In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles
The adsorption of proteins and their layering onto nanoparticle surfaces has been called the
“protein corona”. This dynamic process of protein adsorption has been extensively studied …
“protein corona”. This dynamic process of protein adsorption has been extensively studied …
The human in vivo biomolecule corona onto PEGylated liposomes: a proof‐of‐concept clinical study
M Hadjidemetriou, S McAdam, G Garner… - Advanced …, 2019 - Wiley Online Library
The self‐assembled layered adsorption of proteins onto nanoparticle (NP) surfaces, once in
contact with biological fluids, is termed the “protein corona” and it is gradually seen as a …
contact with biological fluids, is termed the “protein corona” and it is gradually seen as a …
Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles
Nanoparticles (NPs) are instantly modified once injected in the bloodstream because of their
interaction with the blood components. The spontaneous coating of NPs by proteins, once in …
interaction with the blood components. The spontaneous coating of NPs by proteins, once in …
[HTML][HTML] Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses
PI Siafaka, N Üstündağ Okur, E Karavas… - International journal of …, 2016 - mdpi.com
Nanocarriers, due to their unique features, are of increased interest among researchers
working with pharmaceutical formulations. Polymeric nanoparticles and nanocapsules …
working with pharmaceutical formulations. Polymeric nanoparticles and nanocapsules …
[HTML][HTML] LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy
Breast cancer, with around 2 million new cases in 2019, is the second most common cancer
worldwide and the second leading cause of cancer death among females. The aim of this …
worldwide and the second leading cause of cancer death among females. The aim of this …
The nano-plasma interface: Implications of the protein corona
The interactions between nanoparticles and macromolecules in the blood plasma dictate the
biocompatibility and efficacy of nanotherapeutics. Accordingly, the properties of …
biocompatibility and efficacy of nanotherapeutics. Accordingly, the properties of …
[HTML][HTML] In situ detection of the protein corona in complex environments
Colloidal nanoparticles (NPs) are a versatile potential platform for in vivo nanomedicine.
Inside blood circulation, NPs may undergo drastic changes, such as by formation of a …
Inside blood circulation, NPs may undergo drastic changes, such as by formation of a …
Spotlight on the protein corona of liposomes
N Onishchenko, D Tretiakova, E Vodovozova - Acta biomaterialia, 2021 - Elsevier
Although an established drug delivery platform, liposomes have not fulfilled their true
potential. In the body, interactions of liposomes are mediated by the layer of plasma proteins …
potential. In the body, interactions of liposomes are mediated by the layer of plasma proteins …